吉兰-巴雷综合征
Guillain-Barré syndrome.
作者信息
Seneviratne U
机构信息
Institute of Neurology, National Hospital of Sri Lanka, Colombo 8, Sri Lanka.
出版信息
Postgrad Med J. 2000 Dec;76(902):774-82. doi: 10.1136/pmj.76.902.774.
Abstract
Guillain-Barré syndrome is an autoimmune disorder encompassing a heterogeneous group of pathological and clinical entities. Antecedent infections are thought to trigger an immune response, which subsequently cross reacts with nerves leading to demyelination or axonal degeneration. Both intravenous immunoglobulin treatment and plasma exchange have been found to be equally beneficial. Several factors are useful in predicting the outcome of these patients.
摘要
吉兰-巴雷综合征是一种自身免疫性疾病，涵盖了一组病理和临床特征各异的病症。前驱感染被认为会引发免疫反应，随后该反应会与神经发生交叉反应，导致脱髓鞘或轴突变性。静脉注射免疫球蛋白治疗和血浆置换已被证明具有同等疗效。有几个因素有助于预测这些患者的预后。
相似文献
1
Guillain-Barré syndrome.
Postgrad Med J. 2000 Dec;76(902):774-82. doi: 10.1136/pmj.76.902.774.
2
Guillain-Barré syndrome (GBS).
Pharmacol Rep. 2010 Mar-Apr;62(2):220-32. doi: 10.1016/s1734-1140(10)70261-9.
3
Intravenous immunoglobulin for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2001(2):CD002063. doi: 10.1002/14651858.CD002063.
4
Guillain-Barré syndrome.
Am Fam Physician. 2004 May 15;69(10):2405-10.
5
Guillain-Barré syndrome.
Prim Care. 2015 Jun;42(2):189-93. doi: 10.1016/j.pop.2015.01.001. Epub 2015 Mar 20.
6
A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
J Child Neurol. 2019 Apr;34(5):277-283. doi: 10.1177/0883073819826225. Epub 2019 Jan 29.
7
Guillain-Barré syndrome: epidemiology, pathophysiology and management.
Drugs. 2004;64(6):597-610. doi: 10.2165/00003495-200464060-00003.
8
The challenges of managing and treating Guillain-Barré syndrome during the acute phase.
Dimens Crit Care Nurs. 2006 Nov-Dec;25(6):256-63. doi: 10.1097/00003465-200611000-00003.
9
Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis A virus infection.
J Child Neurol. 2009 Jul;24(7):865-7. doi: 10.1177/0883073809332695. Epub 2009 Mar 18.
10
Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Pediatr Neurol. 2006 Jan;34(1):60-2. doi: 10.1016/j.pediatrneurol.2005.06.012.
引用本文的文献
1
Guillain-Barré syndrome in pregnancy: a case report and review of the literature.
AJOG Glob Rep. 2024 Sep 14;4(4):100396. doi: 10.1016/j.xagr.2024.100396. eCollection 2024 Nov.
2
COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.
SN Compr Clin Med. 2020;2(12):2702-2714. doi: 10.1007/s42399-020-00646-w. Epub 2020 Nov 21.
3
Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.
CNS Drugs. 2020 Jan;34(1):1-8. doi: 10.1007/s40263-019-00670-y.
4
Guillain-Barre syndrome with concurrent posterior reversible encephalopathy syndrome and hyponatraemia: mere coincidence or rare coexistence.
BMJ Case Rep. 2019 Jul 11;12(7):e229749. doi: 10.1136/bcr-2019-229749.
5
Emergency Neurological Life Support: Acute Non-traumatic Weakness.
Neurocrit Care. 2017 Sep;27(Suppl 1):29-50. doi: 10.1007/s12028-017-0450-3.
6
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
BMC Neurol. 2016 Sep 5;16(1):161. doi: 10.1186/s12883-016-0687-z.
7
Emergency Neurological Life Support: Acute Non-traumatic Weakness.
Neurocrit Care. 2015 Dec;23 Suppl 2:S23-47. doi: 10.1007/s12028-015-0160-7.
8
Guillain-barré syndrome during active brucellosis.
Eurasian J Med. 2010 Dec;42(3):157-9. doi: 10.5152/eajm.2010.43.
9
Guillain-Barré syndrome presenting with Raynaud's phenomenon: a case report.
BMC Neurol. 2014 Sep 3;14:174. doi: 10.1186/s12883-014-0174-3.
本文引用的文献
1
An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).
N Engl J Med. 1956 Jul 12;255(2):57-65. doi: 10.1056/NEJM195607122550201.
2
Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):180-4. doi: 10.1136/jnnp.67.2.180.
3
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
N Engl J Med. 1998 Dec 17;339(25):1797-802. doi: 10.1056/NEJM199812173392501.
4
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.
Neurology. 1998 Oct;51(4):1110-5. doi: 10.1212/wnl.51.4.1110.
5
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.
Neurology. 1998 Aug;51(2):371-8. doi: 10.1212/wnl.51.2.371.
6
Campylobacter species and Guillain-Barré syndrome.
Clin Microbiol Rev. 1998 Jul;11(3):555-67. doi: 10.1128/CMR.11.3.555.
7
Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ophthalmology. 1998 Jul;105(7):1281-5. doi: 10.1016/S0161-6420(98)97034-8.
8
Guillain-Barré syndrome: MR imaging findings of the spine in eight patients.
Radiology. 1998 Jul;208(1):137-41. doi: 10.1148/radiology.208.1.9646804.
9
Campylobacter jejuni strains from patients with Guillain-Barré syndrome.
Emerg Infect Dis. 1998 Apr-Jun;4(2):263-8. doi: 10.3201/eid0402.980213.
10
Preserved tendon reflexes in Campylobacter neuropathy.
Ann Neurol. 1998 Apr;43(4):546-7. doi: 10.1002/ana.410430424.
Zotero 插件